Impact of IL28B gene polymorphisms rs8099917 and rs12980275 on response to pegylated interferon-α/ribavirin therapy in chronic hepatitis C genotype 4 patients

Mahmoud A Khattab; Hend M Abdelghany; Maggie M Ramzy; Rasha M Khairy

doi:10.7555/JBR.30.20150002

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Impact of IL28B gene polymorphisms rs8099917 and rs12980275 on response to pegylated interferon-α/ribavirin therapy in chronic hepatitis C genotype 4 patients

DOI: 10.7555/JBR.30.20150002

Impact of IL28B gene polymorphisms rs8099917 and rs12980275 on response to pegylated interferon-α/ribavirin therapy in chronic hepatitis C genotype 4 patients

Mahmoud A Khattab

Hend M Abdelghany

Maggie M Ramzy

Rasha M Khairy

Keywords：IL-28B polymorphismhepatitis C virussustained viral responsegenotype

Publication Date：2016-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

The Journal of Biomedical Research

ISSN：1007-4368

Year, Vol.(Issue)：2016,30(1)